Check Before You Invest : Vanta Bioscience Ltd

BSE: 540729 NSE: ISIN: INE695X01011

| Sector: Miscellaneous | Industry: Business Support

Snapshot

Q.1 Which industry/sub-sector does Vanta Bioscience Ltd belong to?

Vanta Bioscience Ltd belongs to the Miscellaneous sector, operating specifically within the Business Support segment.

Q.2 Is Vanta Bioscience Ltd a good quality company?

Vanta Bioscience Ltd is a quality company, based on a 8-year financial track record.

Q.3 Is Vanta Bioscience Ltd undervalued or overvalued?

Vanta Bioscience Ltd appears Overvalued, as its key valuation ratios are above with their past averages.

Q.4 Is Vanta Bioscience Ltd a good buy now?

Vanta Bioscience Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Vanta Bioscience Ltd?

Vanta Bioscience Ltd revenue growth is -86.8% for FY-2025, which is below its 5-year CAGR of -39.31%, indicating slower growth.

Q.2 Return on capital employed (ROCE) of Vanta Bioscience Ltd?

Vanta Bioscience Ltd Return on capital employed is -4.43% for FY-2025, which is below its 5-year historical median of 5.24%. The current ROCE is below its estimated weighted average cost of capital (WACC) of 14%, indicating value preservation.

Q.3 Return on Asset of Vanta Bioscience Ltd?

Vanta Bioscience Ltd Return on Asset is -4.89%, which is below its 5-year historical median of 0.1%, indicating deteriorated asset utilization efficiency.

Q.4 Return on Equity (ROE) of Vanta Bioscience Ltd?

Vanta Bioscience Ltd Return on equity is -14.4% for FY-2025, which is below its 5-year historical median of 0.26%, indicating the business is making worse use of its shareholders capital.

Q.5 Cash conversion cycle of Vanta Bioscience Ltd?

Vanta Bioscience Ltd Cash conversion cycle is 2583 days, above its 5-year historical median of 464 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.

	Current Level	5-year Historic Median
Asset Turnover	0.02	0.16
ROE	-14.4	0.26
ROCE	-4.43	5.24
Cash Conversion Cycle	2583 days	464 days

Q.6 Gross Profit margin of Vanta Bioscience Ltd?

Vanta Bioscience Ltd Gross profit margin which is the profit after deduction of direct costs, is -202.1% for FY-2025, which is below its 5-year median of 14.9%, indicating decreasing margins.

Q.7 Operating Profit Margin of Vanta Bioscience Ltd?

Vanta Bioscience Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is -146.85% for FY-2025, which is below its 5-year median of 36.38% indicating decreasing margins.

Q.8 Net Profit Margin of Vanta Bioscience Ltd?

Vanta Bioscience Ltd Net Profit Margin is -235.88% for FY-2025, is below with its 5-year median of 0.6%, indicating decreasing margins.

	Current Level	5-year Historic Median
Gross Profit Margin	-202.1	14.9
Operating Profit Margin	-146.85	36.38
Net Profit Margin	-235.88	0.6

Q.9 Debt to Equity ratio of Vanta Bioscience Ltd?

Vanta Bioscience Ltd Debt-to-Equity ratio is 1.78, which is above with the industry average of 0.09, indicating higher debt levels in the industry.

Q.10 Debt to cash flow from operations of Vanta Bioscience Ltd?

Vanta Bioscience Ltd Debt to cash flow from operations is 22.38, which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Vanta Bioscience Ltd?

Promoters hold 72.81% of the Vanta Bioscience Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Vanta Bioscience Ltd vs industry peers?

Vanta Bioscience Ltd revenue CAGR is -39.31%, compared to the industry median CAGR of 11.02%, indicating stable growth and maintaining its market share.

Profit Metrics

	Current Level	5-year Industry Median
Revenue Growth	-86.8	11
Gross Profit Growth	-278.1	NAN
Operating Profit Growth	-145.5	14
Net Profit Growth	-5,420	17.7

Operating Efficiency

	Current Level	5-year Industry Median
Asset Turnover	0.02	0.32
ROE	-14.4	6.73
ROCE	-4.43	12.12
Cash Conversion Cycle (days)	2583.09	50

Valuation & price assessment

Q.1 Stock return of Vanta Bioscience Ltd over the last decade?

Over the last 5 year(s), the stock has delivered a CAGR of -36.79% based on the current price.

Q.2 What return has the stock given over the last decade?

	9Y	5Y	3Y	1Y
Share Price CAGR	-	-36.8%	-32.3%	-17.6%

Q.3 Valuation ratios of Vanta Bioscience Ltd vs historical?

The current P/E is lower that its historical median.

Q.4 How do the current valuation ratios compare with 5-year historical median and industry numbers?

Valuation Ratios	Current	5-year Historic Median	5-year Industry Median
Price to Earnings	-	423.46	26.08
Price to Book	0.55	1.64	2.53
Price to Sales	10.25	6.25	5.26
EV to EBITDA	-25.91	17.60	11.21

Check more companies

1. Prime Focus

2. Sagility

3. Syngene Internation.

4. International Gemolo

5. Indegene

6. NESCO

7. Latent View Analytic

8. Smartworks Coworking

9. CMS Info Systems

10. Sun Pharma Adv. Res

Check trending companies

1. PI Industries Ltd.

2. Max Financial Services Ltd.

3. Clean Science And Technology Ltd.

4. Birlasoft Ltd.

5. Redington Ltd.